    [Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
    [Notices]
    [Page 53390]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 2020-18986]

    -----------------------------------------------------------------------

    DEPARTMENT OF HEALTH AND HUMAN SERVICES

    National Institutes of Health

    National Cancer Institute; Notice of Meeting

        Pursuant to section 10(a) of the Federal Advisory Committee Act, as
    amended, notice is hereby given of a meeting of the National Cancer
    Institute Clinical Trials and Translational Research Advisory
    Committee.
        The meeting will be held as a virtual meeting and is open to the
    public. Individuals who plan to view the virtual meeting and need
    special assistance or other reasonable accommodations to view the
    meeting, should notify the Contact Person listed below in advance of
    the meeting. The meeting will be videocast and can be accessed from the
    NIH Videocasting and Podcasting website (http://videocast.nih.gov).

        Name of Committee: National Cancer Institute Clinical Trials and
    Translational Research Advisory Committee.
        Date: November 4, 2020.
        Time: 11:00 a.m. to 3:00 p.m.
        Agenda: Strategic Discussion of NCI's Clinical and Translational
    Research Programs.
        Place: National Cancer Institute Shady Grove, 9609 Medical
    Center Drive, Rockville, MD 20850 (Virtual Meeting).
        Contact Person: Sheila A. Prindiville, M.D., MPH Director,
    Coordinating Center for Clinical Trials, National Institutes of
    Health, National Cancer Institute, Coordinating Center for Clinical
    Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850,
    240-276-6173, prindivs@mail.nih.gov.

        Any interested person may file written comments with the
    committee by forwarding the statement to the Contact Person listed
    on this notice. The statement should include the name, address,
    telephone number and when applicable, the business or professional
    affiliation of the interested person.
        Information is also available on the Institute's/Center's home
    page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
    agenda and any additional information for the meeting will be posted
    when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392,
    Cancer Construction; 93.393, Cancer Cause and Prevention Research;
    93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
    Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
    Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
    Control, National Institutes of Health, HHS)

        Dated: August 25, 2020.
    Melanie J. Pantoja,
    Program Analyst, Office of Federal Advisory Committee Policy.
    [FR Doc. 2020-18986 Filed 8-27-20; 8:45 am]
    BILLING CODE 4140-01-P